X

Company profile for Kantum Pharma

Kantum Pharma

KANTUM PHARMA

About, Contact Details

EVENTS

Webinars & Exhibitions

Webinars & Exhibitions

PRESENTATION(s)

No Presentations

VIDEO(s)

No Video

DIGITAL CONTENT

No Content

DEVELOPMENTS

1 Drug(s) in Development

1 Drug(s) in Development

Contact Supplier

Related Companies

Kantum Pharma was founded based on pioneering work from the laboratory of our scientific founder, Dr. Sylvie Breton, at MGH/Harvard Medical School. The Company is focused on translating her important research on the UDP-glucose/P2Y14 receptor signaling pathway into potentially transformative therapies in order to improve outcomes and patients’ lives. The company’s lead program, KB-1801, is based on technology licensed...

Kantum Pharma was founded based on pioneering work from the laboratory of our scientific founder, Dr. Sylvie Breton, at MGH/Harvard Medical School. The Company is focused on translating her important research on the UDP-glucose/P2Y14 receptor signaling pathway into potentially transformative therapies in order to improve outcomes and patients’ lives. The company’s lead program, KB-1801, is based on technology licensed from MGH and is currently in preclinical development for prevention of acute kidney injury.